Outcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant

被引:2
作者
Chan, Edie Y. [1 ]
Bhattacharya, Renuka [2 ]
Eswaran, Sheila [3 ]
Hertl, Martin [1 ]
Shah, Nikunj [3 ]
Fayek, Sameh [1 ]
Cohen, Eric B. [3 ]
Hollinger, Edward F. [1 ]
Olaitan, Oyedolamu [1 ]
Jensik, Stephen C. [1 ]
Perkins, James D. [4 ]
机构
[1] Rush Univ, Med Ctr, Dept Gen Surg, Chicago, IL 60612 USA
[2] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA
[3] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA
[4] Univ Washington, Med Ctr, Dept Surg, Seattle, WA 98195 USA
关键词
cirrhosis; combined liver-kidney transplant; kidney transplant; liver transplant; outcomes; C VIRUS-INFECTION; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; CIRRHOSIS; SURVIVAL; FIBROSIS; MORTALITY; PRESSURE; PATIENT; IMPACT;
D O I
10.1111/ctr.12484
中图分类号
R61 [外科手术学];
学科分类号
摘要
IntroductionThe decision for isolated kidney transplant (KT) vs. combined liver-kidney transplant (CLKT) in patients with end-stage renal disease (ESRD) with compensated cirrhosis remains controversial. We sought to determine outcomes of patients requiring listing for a liver transplant (LT) following either a cadaveric or living donor KT and compare these outcomes to similar patients receiving a CLKT. MethodsOur dataset included the United Network for Organ Sharing (UNOS)/Standard Transplant and Analysis and Research (STAR) kidney files from 1987 to 2012 after being joined with the liver files from 2002 to 2012. Outcomes of patients who received a CLKT with an international normalized ratio (INR) 1 and total bilirubin 1 were compared to patients who received a primary KT and subsequently required listing for LT between zero and fiveyr or after fiveyr. ResultsFor the three groups, 244 patients had a CLKT, 216 were wait-listed for LT between zero and fiveyr after KT (0-5 WL), and 320 were wait-listed fiveyr after KT (+5 WL). From the time of KT, the 0-5 WL group had significantly worse survival than the CLKT group and the +5 WL group. The +5 WL had the best survival of all groups. For the 0-5 WL group, 45% underwent LT and 40% died while waiting compared to the +5 WL group with 53% having LT and 26% died while waiting. At the time of LT, the 0-5 WL group had a higher model for end-stage liver disease (MELD) score, higher incidence of being in the ICU at the time of transplant, and higher incidence of requiring life support. From the time of LT, the CLKT trended toward better survival (p=0.0549) than both the 0-5 WL and +5 WL groups, which had equivalent survival. ConclusionThe 0-5 WL group is a higher risk group with poorer survival due to a higher incidence of dying on the waitlist. Better identification of patients with a high risk for hepatic decompensation following KT and agreement for regional exception for LT in the event of decompensation may improve utilization of organs and better survival for those patients.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 16 条
[1]   Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure [J].
Bruix, J ;
Castells, A ;
Bosch, J ;
Feu, F ;
Fuster, J ;
GarciaPagan, JC ;
Visa, J ;
Bru, C ;
Rodes, J .
GASTROENTEROLOGY, 1996, 111 (04) :1018-1022
[2]   Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates [J].
Campbell, Mical S. ;
Constantinescu, Serban ;
Furth, Emma E. ;
Reddy, K. Rajender ;
Bloom, Roy D. .
DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (10) :2501-2507
[3]   Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK) [J].
Eason, J. D. ;
Gonwa, T. A. ;
Davis, C. L. ;
Sung, R. S. ;
Gerber, D. ;
Bloom, R. D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) :2243-2251
[4]   Antiviral treatment of hepatitis C [J].
Feeney, Eoin R. ;
Chung, Raymond T. .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[5]   Analysis of the united network for organ sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney or kidney-pancreas transplantation [J].
Fong, TL ;
Bunnapradist, S ;
Jordan, SC ;
Selby, RR ;
Cho, YW .
TRANSPLANTATION, 2003, 76 (02) :348-353
[6]   Treatment of Hepatitis C A Systematic Review [J].
Kohli, Anita ;
Shaffer, Ashton ;
Sherman, Amy ;
Kottilil, Shyam .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (06) :631-640
[7]   Impact of Donor Hepatitis C Virus Infection Status on Death and Need for Liver Transplant in Hepatitis C Virus-Positive Kidney Transplant Recipients [J].
Kucirka, Lauren M. ;
Peters, Thomas G. ;
Segev, Dorry L. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (01) :112-120
[8]   Hepatitis C virus infection and kidney transplantation: Predictors of patient and graft survival [J].
Maluf, Daniel G. ;
Fisher, Robert A. ;
King, Anne L. ;
Gibney, Eric M. ;
Mas, Valeria R. ;
Cotterell, Adrian H. ;
Shiffman, Mitchell L. ;
Sterling, Richard K. ;
Behnke, Martha ;
Posner, Marc P. .
TRANSPLANTATION, 2007, 83 (07) :853-857
[9]   Abdominal operations in patients with cirrhosis: Still a major surgical challenge [J].
Mansour, A ;
Watson, W ;
Shayani, V ;
Pickleman, J .
SURGERY, 1997, 122 (04) :730-735
[10]   Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies [J].
Morgan, Rebecca L. ;
Baack, Brittney ;
Smith, Bryce D. ;
Yartel, Anthony ;
Pitasi, Marc ;
Falck-Ytter, Yngve .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (05) :329-+